Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Study of Tumor Treating Fields Combined with Gemcitabine and Albumin-bound Paclitaxel in the First-line Treatment of Locally Advanced Pancreatic Cancer

NCT05653453 is registered in ClinicalTrials.gov with Jiangsu Healthy Life Innovation Medical Technology Co., Ltd as lead sponsor.

NCT NCT05653453
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05653453 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Study of Tumor Treating Fields Combined with Gemcitabine and Albumin-bound Paclitaxel in the First-line Treatment of Locally Advanced Pancreatic Cancer
Lead sponsor
Jiangsu Healthy Life Innovation Medical Technology Co., Ltd
Phase
Phase 3
Overall status
Recruiting
Start date
December 20, 2022
Completion date
September 28, 2027
Enrollment
512 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

locally advanced pancreatic cancer